Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ernst J. Postema"'
Autor:
Anna Kuisma, Simona Malaspina, Mika Scheinin, Ernst J. Postema, Kalle Mattila, Kari K. Kalliokoski, Peter J. Boström, Otto Ettala, Matthew P. Miller, Heikki Minn, Vesa Oikonen
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose This phase 1 open-label study evaluated the uptake kinetics of a novel theranostic PET radiopharmaceutical, 18F-rhPSMA-7.3, to optimise its use for imaging of prostate cancer. Methods Nine men, three with high-risk localised prostate cancer,
Autor:
Simona Malaspina, Matthew P. Miller, Salla Lahdenpohja, Kari K. Kalliokoski, Anna Kuisma, Tuula Tolvanen, Mika Scheinin, Ernst J. Postema
Publikováno v:
Journal of Nuclear Medicine. 62:679-684
This first-in-human study investigated the safety, biodistribution and radiation dosimetry of the novel 18F-labeled radiohybrid prostate-specific membrane antigen (rhPSMA) positron emission tomography (PET) imaging agent, 18F-rhPSMA-7.3. Methods: Six
Autor:
Simona, Malaspina, Pekka, Taimen, Markku, Kallajoki, Vesa, Oikonen, Anna, Kuisma, Otto, Ettala, Kalle, Mattila, Peter J, Boström, Heikki, Minn, Kari, Kalliokoski, Ernst J, Postema, Matthew P, Miller, Mika, Scheinin
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 37(3)
Autor:
Tuula, Tolvanen, Kari, Kalliokoski, Simona, Malaspina, Anna, Kuisma, Salla, Lahdenpohja, Ernst J, Postema, Matthew P, Miller, Mika, Scheinin
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 62(5)
This first-in-humans study investigated the safety, biodistribution, and radiation dosimetry of a novel
Autor:
Piyush Kumar, Ernst J. Postema, Dacia A. Richmond, Leonard I. Wiebe, Douglas N. Abrams, Alexander J.B. McEwan, T. Riauka
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 36:1565-1573
Tumour hypoxia is thought to play a significant role in the outcome of solid tumour therapy. Positron emission tomography (PET) is the best-validated noninvasive technique able to demonstrate the presence of hypoxia in vivo. The locally developed PET
Autor:
Ernst J. Postema, Josée M. Zijlstra, Eric J.F. Franssen, Marieke G.G. Sturkenboom, Otto S. Hoekstra, Johannes Berkhof
Publikováno v:
Molecular Imaging and Biology
Molecular Imaging and Biology, 11(5), 364-368. Springer New York
Sturkenboom, M G G, Hoekstra, O S, Postema, E J, Zijlstra-Baalbergen, J M, Berkhof, J & Franssen, E J F 2009, ' A Randomised Controlled Trial Assessing the Effect of Oral Diazepam on F-18-FDG Uptake in the Neck and Upper Chest Region ', Molecular Imaging and Biology, vol. 11, no. 5, pp. 364-368 . https://doi.org/10.1007/s11307-009-0207-2
Molecular Imaging and Biology, 11(5), 364-368. SPRINGER
Molecular Imaging and Biology, 11(5), 364-368. Springer New York
Sturkenboom, M G G, Hoekstra, O S, Postema, E J, Zijlstra-Baalbergen, J M, Berkhof, J & Franssen, E J F 2009, ' A Randomised Controlled Trial Assessing the Effect of Oral Diazepam on F-18-FDG Uptake in the Neck and Upper Chest Region ', Molecular Imaging and Biology, vol. 11, no. 5, pp. 364-368 . https://doi.org/10.1007/s11307-009-0207-2
Molecular Imaging and Biology, 11(5), 364-368. SPRINGER
Objective A distinctive pattern of physiological symmetrical uptake of 18F-fluorodeoxyglucose (18F-FDG) in the neck and upper chest region is a phenomenon that is sometimes observed on positron emission tomography (PET) scans of some oncologic patien
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry, 7, 335-43
Anti-Cancer Agents in Medicinal Chemistry, 7, 3, pp. 335-43
Anti-Cancer Agents in Medicinal Chemistry, 7, 3, pp. 335-43
Contains fulltext : 52855.pdf (Publisher’s version ) (Closed access) Radioimmunotherapy (RIT) using radiolabeled monoclonal antibodies (MAbs) directed against tumor-associated antigens has evolved from an appealing concept to one of the standard tr
Autor:
Henri A. M. Marres, Matthias A.W. Merkx, Frank J. A. van den Hoogen, Wouter V. Vogel, Bart M Wensing, Ernst J. Postema, Wim J.G. Oyen
Publikováno v:
Laryngoscope, 116, 5, pp. 809-13
Laryngoscope, 116, 809-13
Laryngoscope, 116, 809-13
Contains fulltext : 39561.pdf (Publisher’s version ) (Closed access) OBJECTIVE: With improved diagnostic imaging techniques, it remains difficult to reduce occult metastatic disease in oral squamous cell carcinoma (SCC) to less than 20%. Therefore,
Autor:
Otto C. Boerman, Frans H.M. Corstens, J.M.M. Raemaekers, David M. Goldenberg, Wim J.G. Oyen, Cathelijne Frielink, Ernst J. Postema
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals, 18, 4, pp. 525-33
Cancer Biotherapy & Radiopharmaceuticals, 18, 525-33
Cancer Biotherapy & Radiopharmaceuticals, 18, 525-33
Item does not contain fulltext Radioimmunotherapy (RIT) is a new and effective treatment modality in patients with non-Hodgkin's lymphoma. The monoclonal antibody (mAb) hLL2 (epratuzumab), a humanized mAb directed against the CD22 antigen, and which
Publikováno v:
European Journal of Nuclear Medicine, 28, 11, pp. 1725-35
ResearcherID
European Journal of Nuclear Medicine, 28, 1725-35
ResearcherID
European Journal of Nuclear Medicine, 28, 1725-35
Item does not contain fulltext In the past decade, several new antibody-based therapies - using either radiolabelled or unlabelled monoclonal antibodies - have become available for the treatment of patients with refractory or recurrent non-Hodgkin's